1.
Growth and the Growth Hormone-Insulin Like Growth Factor 1 Axis in Children With Chronic Inflammation: Current Evidence, Gaps in Knowledge, and Future Directions
by Wong, S. C
Endocrine reviews, 2016-02, Vol.37 (1), p.62-110
2.
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
by Abou-Alfa, Ghassan K
The lancet oncology, 2020-05, Vol.21 (5), p.671-684
3.
Strigolactone inhibition of shoot branching
by Gomez-Roldan, M.V
Nature, 2008, Vol.455 (7210), p.189-195
4.
Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1
by Carmeliet, Peter
Nature medicine, 2002-08, Vol.8 (8), p.831-840
5.
Glucagon Decreases IGF-1 Bioactivity in Humans, Independently of Insulin, by Modulating Its Binding Proteins
by Sarem, Zeinab
The journal of clinical endocrinology and metabolism, 2017-09, Vol.102 (9), p.3480-3490
6.
Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells
by Xian, Lingling
Nature medicine, 2012-07, Vol.18 (7), p.1095-1101
7.
Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like...
by Grimberg, Adda
Hormone research in paediatrics, 2016, Vol.86 (6), p.361-397
8.
Population aging and endogenous economic growth
by Prettner, Klaus
Journal of population economics, 2013-04-01, Vol.26 (2), p.811-834
9.
Long-Term Mortality and Causes of Death in Isolated GHD, ISS, and SGA Patients Treated with Recombinant Growth Hormone during Childhood in Belgium, The Netherlands, and Sweden: Pre...
by Sävendahl, Lars
The journal of clinical endocrinology and metabolism, 2012-02, Vol.97 (2), p.E213-E217
10.
FGFR inhibitors for advanced cholangiocarcinoma
by Yang, Tian
The lancet oncology, 2020-05, Vol.21 (5), p.610-612
11.
TGF-β Signaling Pathways in Different Compartments of the Lower Airways of Patients With Stable COPD
by Di Stefano, Antonino
Chest, 2018-04, Vol.153 (4), p.851-862
12.
Inhibition of shoot branching by new terpenoid plant hormones
by Yamaguchi, Shinjiro
Nature, 2008-09-11, Vol.455 (7210), p.195-200
13.
Structural and Functional Evidence for the Interaction of Insulin-Like Growth Factors (IGFs) and IGF Binding Proteins with Vitronectin
by Kricker, Jennifer A
Endocrinology (Philadelphia), 2003-07, Vol.144 (7), p.2807-2815
14.
Liver-Specific GH Receptor Gene-Disrupted (LiGHRKO) Mice Have Decreased Endocrine IGF-I, Increased Local IGF-I, and Altered Body Size, Body Composition, and Adipokine Profiles
by List, Edward O
Endocrinology (Philadelphia), 2014-05, Vol.155 (5), p.1793-1805
15.
Looking for age-related growth decline in natural forests: unexpected biomass patterns from tree rings and simulated mortality
by Foster, Jane R
Oecologia, 2014-05-01, Vol.175 (1), p.363-374
16.
Characterizing Short Stature by Insulin-like Growth Factor Axis Status and Genetic Associations: Results From the Prospective, Cross-sectional, Epidemiogenetic EPIGROW Study
by Clayton, Peter
The journal of clinical endocrinology and metabolism, 2013-06, Vol.98 (6), p.E1122-E1130
17.
Androgen receptor in human prostate cancer-associated fibroblasts promotes prostate cancer epithelial cell growth and invasion
by Yu, Shengqiang
Medical oncology (Northwood, London, England), 2013-08-08, Vol.30 (3), p.674-674
18.
GROWTH IN THE SHADOW OF EXPROPRIATION
by Aguiar, Mark
The Quarterly journal of economics, 2011-05-01, Vol.126 (2), p.651-697
19.
Klotho converts canonical FGF receptor into a specific receptor for FGF23
by Fukumoto, Seiji
Nature, 2006-12-07, Vol.444 (7120), p.770-774
20.
Endocrine Actions of Myostatin: Systemic Regulation of the IGF and IGF Binding Protein Axis
by Williams, Nolann G
Endocrinology (Philadelphia), 2011-01, Vol.152 (1), p.172-180
